Literature DB >> 7901527

Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys.

P Fioretto1, S M Mauer, R W Bilous, F C Goetz, D E Sutherland, M W Steffes.   

Abstract

Pancreas transplantation prevents or retards development of early diabetic glomerular lesions in renal allografts transplanted to patients with insulin-dependent diabetes mellitus (IDDM), but its effect on established renal lesions in native kidneys of such patients is unknown. Renal biopsy samples were taken before and 5 years after pancreas transplantation from 13 non-uraemic IDDM patients and compared with baseline and 5-year biopsy samples from 10 persistently hyperglycaemic IDDM patients who did not undergo transplantation. The two groups were similar in age, duration of diabetes, metabolic control, renal function, and blood pressure. Glomerular structures were measured by standard morphometric techniques. Haemoglobin A1 concentrations fell to within the normal range after pancreas transplantation but did not change in the comparison group. Glomerular basement membrane width did not significantly change in either group. Glomerular volume decreased and mesangial fractional volume increased in the pancreas transplant recipients but there was no significant change in total mesangial volume over 5 years. By contrast, both glomerular volume and mesangial fractional volume increased in the comparison patients, resulting in increased total mesangial volume. Diabetic glomerular lesions in patients with their own kidneys were not ameliorated by pancreas transplantation, despite 5 years of normoglycaemia. Pancreas transplantation can correct severe metabolic instability and thus improve quality of life, but it cannot yet be recommended for the treatment of established lesions of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901527     DOI: 10.1016/0140-6736(93)92183-t

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

Review 1.  Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

Authors:  Emaad M Abdel-Rahman; Lawand Saadulla; W Brian Reeves; Alaa S Awad
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

2.  The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects.

Authors:  M Lind; A Odén; M Fahlén; B Eliasson
Journal:  Diabetologia       Date:  2010-03-18       Impact factor: 10.122

3.  Differential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 Diabetes.

Authors:  M Luiza Caramori; Youngki Kim; Rama Natarajan; Jason H Moore; Stephen S Rich; Josyf C Mychaleckyj; Ryoko Kuriyama; David Kirkpatrick; Michael Mauer
Journal:  J Clin Endocrinol Metab       Date:  2015-04-22       Impact factor: 5.958

Review 4.  Lessons learned from more than 1,000 pancreas transplants at a single institution.

Authors:  D E Sutherland; R W Gruessner; D L Dunn; A J Matas; A Humar; R Kandaswamy; S M Mauer; W R Kennedy; F C Goetz; R P Robertson; A C Gruessner; J S Najarian
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

Review 5.  Extracellular Matrix Scaffold Technology for Bioartificial Pancreas Engineering: State of the Art and Future Challenges.

Authors:  Marcus Salvatori; Ravi Katari; Timil Patel; Andrea Peloso; Jon Mugweru; Kofi Owusu; Giuseppe Orlando
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

Review 6.  Pancreas and kidney transplantation.

Authors:  Jennifer Larsen; James Lane; Lynn Mack-Shipman
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

7.  Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering.

Authors:  Sayed-Hadi Mirmalek-Sani; Giuseppe Orlando; John P McQuilling; Rajesh Pareta; David L Mack; Marcus Salvatori; Alan C Farney; Robert J Stratta; Anthony Atala; Emmanuel C Opara; Shay Soker
Journal:  Biomaterials       Date:  2013-04-10       Impact factor: 12.479

8.  Counterpoint: clinical islet transplantation: not ready for prime time.

Authors:  Mahfuzul H Khan; David M Harlan
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 19.112

Review 9.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 10.  Biomarkers in pancreas transplant.

Authors:  George W Burke; Linda J Chen; Gaetano Ciancio; Alberto Pugliese
Journal:  Curr Opin Organ Transplant       Date:  2016-08       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.